Hyperthyroidism in two patients with Crohn disease and Takayasu arteritis

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 8, 2003, Pages 901-903

  Kettaneh, Adrien ^a   Prevot, S ^b   Biaggi, A ^b   Stirnemann, J ^b   Fain, O ^b   Hocqueloux, L ^b   Mouas, H ^b   Levy, V G ^b   Thomas, M ^b  

^a HÔPITAL JEAN VERDIER   (France)

^b NONE

Author keywords

Case report; Crohn disease; Takayasu arteritis; Thyroid

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IODINE; IODINE 123; PROPYLTHIOURACIL; THYROID ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; ECHOGRAPHY; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOTHESIS; IMAGE ANALYSIS; PRIORITY JOURNAL; THYROID NODULE; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTOXICOSIS; TREATMENT OUTCOME;

ADULT; CROHN DISEASE; FEMALE; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; TAKAYASU'S ARTERITIS;

EID: 0042428847     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310003912     Document Type: Article

References (27)

1. Biagi P, Castro R, Gullino E, Campanella G, Bianconi E. Takayasu's arteritis associated with Crohn's disease. Report of a case. Panminerva Med 2000;42:83-5.
2. Todini AR, Heinzmann MM, Antignani PL, Paiella ML. Association between Takayasu's arteritis and Crohn's disease in two young women: case reports. J Mal Vasc 1999;24:373-6.
3. Hilario MO, Terreri MT, Prismich G, Len C, Kihara EN, Goldenberg J, et al. Association of ankylosing spondylitis, Crohn's disease and Takayasu's arteritis in a child. Clin Exp Rheumatol 1998;16:92-4.
4. Messina G, Viceconti N, Triati B. The clinical and echographic assessment of thyroid function and structure in patients with a chronic inflammatory intestinal disease. Recenti Prog Med 1999;90:13-6.
5. Bianchi GP, Marchesini G, Gueli C, Zoli M. Thyroid involvement in patients with active inflammatory bowel diseases. Ital J Gastroenterol 1999;27:291-5.
6. Shah SA, Peppercorn MA, Pallotta JA. Autoimmune (Hashimoto's) thyroiditis associated with Crohn's disease. J Clin Gastroenterol 1998;26:117-20.
7. Gomez R, Shetty AK, Vargas A, Tilton AH, England JD, Gedalia A, et al. Chronic inflammatory demyelinating polyradiculoneurophathy and Graves' disease in an adolescent with Crohn's disease. J Pediatr Gastroenterol Nutr 1999;29:91-4.
8. D'Antonio A, Franco R, Sparano L, Terzi G, Pettinato G. Amyloid goiter: the first evidence in secondary amyloidosis. Report of five cases and review of the literature. Recent Adv Clin Path 2000;4:99-106.
9. Habu S, Watanobe H, Kimura K, Suda T. A case of amyloid goiter secondary to Crohn's disease. Endocr J 1999;46:179-82.
10. Greenstein AJ, Sachar DB, Panday AK, Dikman SH, Meyers S, Heimann T, et al. Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) 1992;7:261:70.
11. Jarnerot G. The thyroid in ulcerative colitis and Crohn's disease. I. Thyroid radioiodide uptake and urinary iodine excretion. Acta Med Scand 1975;197:77-81.
12. Jarnerot G, Truelove SC, Warner GT. The thyroid in ulcerative colitis and Crohn's disease. III. The daily fractional turnover of thyroxine. Acta Med Scand 1975;197:89-94.
13. Simi M, Levenstein S, Giri S, Leardi S, Prantera C, Speranza V. Exaggerated response of thyrotropin to thyrotropin-releasing hormone in patients resected for Crohn's ileitis. Dig Dis Sci 1985;30:134-8.
14. Valeix P, Zarebska M, Preziosi P, Galan P, Pelletier B, Hercberg S. Iodine deficiency in France. Lancet 1999;353:1766-7.
15. Laurberg P, Bulow Pedersen I, Pedersen KM, Vestergaard H. Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake. Thyroid 1999;9:33-8.
16. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol 2000;143:485-91.
17. Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol 1999;51:361-7.
18. Stewart JC, Vidor GI, Buttfield IH, Hetzel BS. Epidemic thyrotoxicosis in northern Tasmania: studies of clinical features and iodine nutrition. Aust NZ J Med. 1971;3:203-11.
19. Ermans AM, Mugisho Soron'gana E, Tonglet R, Mukalay WA, Mukalay A, Tshibangu Matway J, et al. Thyrotoxicosis induced by consumption of highly iodinated salt in severely iodine deficient population in Kivu, Zaire. Lancet 1996;347:552-3.
20. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
21. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
22. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
23. Blank M, Krause I, Goldkorn T, Praprotnik S, Livneh A, Langevitz P, et al. Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999;42:1421-32.
24. Lee SK, Kim JH, Lee YC, Cheong J, Lee JW. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J Biol Chem 2000; 275:12470-4.
25. Thomas G, Bertrand F, Saunier B. The differential regulation of group IIA and group V low molecular weight phospholipases A2 in cultured rat astrocytes. J Biol Chem 2000;275:10876-86.
26. Kikumori T, Kambe F, Nagaya T, Funahashi H, Seo H. Thyrotropin modifies activation of nuclear factor kappa B by tumour necrosis factor alpha in rat thyroid cell line. Biochem J 2001;354:573-9.
27. Taniguchi SI, Shong M, Giuliani C, Napolitano G, Saji M, Montani V, et al. Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kappa B. Mol Endocrinol 1998;12:19-33.